191 related articles for article (PubMed ID: 29437467)
21. DART-MS in-source collision induced dissociation and high mass accuracy for new psychoactive substance determinations.
Musah RA; Cody RB; Domin MA; Lesiak AD; Dane AJ; Shepard JR
Forensic Sci Int; 2014 Nov; 244():42-9. PubMed ID: 25194642
[TBL] [Abstract][Full Text] [Related]
22. Multi-class analysis of new psychoactive substances and metabolites in hair by pressurized liquid extraction coupled to HPLC-HRMS.
Montesano C; Vannutelli G; Massa M; Simeoni MC; Gregori A; Ripani L; Compagnone D; Curini R; Sergi M
Drug Test Anal; 2017 May; 9(5):798-807. PubMed ID: 27448433
[TBL] [Abstract][Full Text] [Related]
23. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
[TBL] [Abstract][Full Text] [Related]
24. An investigation of the stability of emerging new psychoactive substances.
Soh YN; Elliott S
Drug Test Anal; 2014; 6(7-8):696-704. PubMed ID: 24573920
[TBL] [Abstract][Full Text] [Related]
25. Identification and quantification of synthetic cathinones in blood and urine using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry.
Glicksberg L; Bryand K; Kerrigan S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1035():91-103. PubMed ID: 27697731
[TBL] [Abstract][Full Text] [Related]
26. Target and suspect screening of psychoactive substances in sewage-based samples by UHPLC-QTOF.
Baz-Lomba JA; Reid MJ; Thomas KV
Anal Chim Acta; 2016 Mar; 914():81-90. PubMed ID: 26965330
[TBL] [Abstract][Full Text] [Related]
27. X-Ray powder diffraction - A non-destructive and versatile approach for the identification of new psychoactive substances.
Jurásek B; Bartůněk V; Huber Š; Kuchař M
Talanta; 2019 Apr; 195():414-418. PubMed ID: 30625563
[TBL] [Abstract][Full Text] [Related]
28. [Practical analysis of toxic substances useful for clinical toxicology. (3) Detection methods of cathinone compounds].
Saito T
Chudoku Kenkyu; 2013 Sep; 26(3):246-50. PubMed ID: 24224391
[No Abstract] [Full Text] [Related]
29. Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples.
Salomone A; Gazzilli G; Di Corcia D; Gerace E; Vincenti M
Anal Bioanal Chem; 2016 Mar; 408(8):2035-42. PubMed ID: 26680593
[TBL] [Abstract][Full Text] [Related]
30. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
Adamowicz P; Tokarczyk B
Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
[TBL] [Abstract][Full Text] [Related]
31. GC-MS analysis of underivatised new psychoactive substances in whole blood and urine.
Alexandridou A; Mouskeftara T; Raikos N; Gika HG
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122308. PubMed ID: 33038866
[TBL] [Abstract][Full Text] [Related]
32. Investigating the appearance of new psychoactive substances in South Australia using wastewater and forensic data.
Bade R; Stockham P; Painter B; Celma A; Bijlsma L; Hernandez F; White JM; Gerber C
Drug Test Anal; 2019 Feb; 11(2):250-256. PubMed ID: 30129282
[TBL] [Abstract][Full Text] [Related]
33. Detection of synthetic cathinones in victims of sexual assault.
Hagan KS; Reidy L
Forensic Sci Int; 2015 Dec; 257():71-75. PubMed ID: 26301833
[TBL] [Abstract][Full Text] [Related]
34. Identification and analytical characterization of the synthetic cathinone N-butylhexedrone.
Shevyrin V; Eltsov O; Shafran Y
Drug Test Anal; 2020 Jan; 12(1):159-163. PubMed ID: 31667946
[No Abstract] [Full Text] [Related]
35. Detection and elimination profile of cathinone in equine after norephedrine (Propalin®) administration using a validated liquid chromatography-tandem mass spectrometry method.
Yi R; Zhao S; Lam G; Sandhu J; Loganathan D; Morrissey B
Anal Bioanal Chem; 2013 Dec; 405(30):9711-22. PubMed ID: 23954941
[TBL] [Abstract][Full Text] [Related]
36. Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.
Ambach L; Redondo AH; König S; Angerer V; Schürch S; Weinmann W
Bioanalysis; 2015; 7(9):1119-36. PubMed ID: 26039809
[TBL] [Abstract][Full Text] [Related]
37. Sample preparation strategies for the determination of psychoactive substances in biological fluids.
Esteve-Turrillas FA; Armenta S; de la Guardia M
J Chromatogr A; 2020 Dec; 1633():461615. PubMed ID: 33099196
[TBL] [Abstract][Full Text] [Related]
38. Clinical toxicology and management of intoxications with synthetic cathinones ("bath salts").
Mas-Morey P; Visser MH; Winkelmolen L; Touw DJ
J Pharm Pract; 2013 Aug; 26(4):353-7. PubMed ID: 23178412
[TBL] [Abstract][Full Text] [Related]
39. New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study.
de Souza Boff B; Silveira Filho J; Nonemacher K; Driessen Schroeder S; Dutra Arbo M; Rezin KZ
Forensic Sci Int; 2020 Jan; 306():110002. PubMed ID: 31864775
[TBL] [Abstract][Full Text] [Related]
40. Biomedical analysis of New Psychoactive Substances (NPS) of natural origin.
Lo Faro AF; Di Trana A; La Maida N; Tagliabracci A; Giorgetti R; Busardò FP
J Pharm Biomed Anal; 2020 Feb; 179():112945. PubMed ID: 31704129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]